Message #13 From:
Stock News Bot Date: September 29, 2006 08:03:00 AM
GTHA News GeneThera, Inc. CEO Discusses Research Report Podcasted on MN1.com
DALLAS--(BUSINESS WIRE)--Dr. Tony Milici, CEO of GeneThera, Inc. (OTCBB:GTHA.OB), spoke with
Research Analyst Mike Willingham from MN1.com in a recent press
conference. Willingham recently completed a thorough review of GeneThera
operations and invited Milici to join him in a discussion regarding the
report and its findings.
Follow this link (http://www.marketnewsfirst.com/mp3/GTHA_092206.MP3)
to listen to the archived interview or find it on the MN1.com website.
Simply go to www.MN1.com, enter GTHA in
the “Profile” box,
and find the archived segment with Milici and Willingham toward the
bottom of the Profile page. You will find yourself informed and rather
intrigued by the business at GTHA as well as Dr. Milici’s
plans for the future.
About GeneThera, Inc.
GeneThera, Inc. is a molecular biotechnology company located in Wheat
Ridge, CO. The Company provides genetic diagnostic solutions for the
veterinary and agricultural industries with future plans to include the
health-care industry. The Company's proprietary diagnostic solution is
based on a genetic expression assay, GEA(TM), a protocol designed to
function on a highly automated Fluorogenic PCR platform. This platform
enables GeneThera to offer tests that are presently not available from
other technologies. The GEA(TM) is designed for a host of individual
diseases, the current priority being Mad Cow Disease, Chronic Wasting
Disease, a disease affecting elk and deer in North America; E.Coli
0157:H7 and Johnne's Disease, diseases affecting cattle worldwide. The
company is currently focusing on the two molecular laboratories they are
planning to open outside the US to treat cattle for mad cow disease and
Johnne's disease. GeneThera has an agreement with Istituto
Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna to
collaborate on scientific research related to the diagnosis of animal
transmittable diseases, such as Mad Cow Disease and Scrapie. The other
laboratory will be located in Mexico where they will be focusing on
Johnne's disease.
About MN1.com
Market News First is an online, market news provider that brings
investors current news regarding investments, entertainment, and sports.
Market News First is the only live online video webcast that brings real
news to its audience while featuring live interaction with companies
from the Bulletin Board to the NYSE.
Through daily, live interviews, we bring you up to date on all the
established companies and inform the investors of the newest
opportunities within the market. Market News First offers one-on-one
interviews with the CEOs and CFOs of companies to deliver answers to the
questions that investors are concerned with most. This provides viewers
the ever-important insight into the companies’
present condition and future plans. Tune into MN1.com for our live video
webcast each weekday from 8:30 a.m. to 8:00 p.m. Eastern time.
Safe Harbor Act Disclaimer: Forward-looking statements in this release
are made pursuant to the Safe Harbor Provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to certain risks, and uncertainties and actual
results could differ from those discussed. This material is information
only and is not an offer or solicitation to buy or sell the securities.
